Recombinant proteins are used in development of novel therapies for
severe chronic diseases such as cancer and other rare diseases.
Recombinant protein production requires a special technique known as
recombinant DNA (rDNA) technology. Recombinant proteins have immense
potential in cancer therapy research and development. For instance,
growth factors, immune checkpoint, and cell damage & oxidative
stress proteins (preclinical stage) are utilized from recombinant
proteins category for cancer therapy research.
Market
Dynamics
Increasing demand for recombinant proteins for basic research has
supported growth of the custom recombinant protein production
services market. Recombinant therapeutic proteins are one of the
fast-growing areas in molecular medicine. Various biopharmaceutical
companies are focusing on development of biologics and subsequently
biosimilars. Moreover, increasing expenditure in research has
supported the market growth. The R&D spending of the U.S. is
around 2.7% of its Gross Domestic Products (GDP) with highest R&D
investments observed in the biotechnology segment in 2014, according
to American Pharmaceutical Review.
Request
Sample of Report:
https://www.coherentmarketinsights.com/insight/request-sample/2737
Increasing
funding in the field of life sciences is expected to propel growth of
the custom recombinant protein production services market
Recombinant protein is a manipulated form of protein, which is
encoded by genes. It is used in production of large quantities of
protein, which is further used for manufacturing of therapeutic
commercial products. Increasing government initiatives and funding in
the field of life sciences is expected to boost growth of the market.
For instance, Life Sciences Greenhouse of Central Pennsylvania offers
early stage funding of up to US$ 1-2 million in the form of
convertible debt or equity financing to viable life sciences
companies, which have significant potential for commercial growth.
Moreover, advancements in bioreactor systems have facilitated
production of recombinant protein within shorter time span, which in
turn is expected to propel growth of the custom recombinant protein
production services market over the forecast period. For instance,
according to National Centre for Biotechnology Information (NCBI), in
2014, around 65.6% of clinical scale manufacturers and 42% of
commercial manufacturers adopted single-use bioreactors for
improvement in their bioprocessing.
Increasing
research and development and product launches in North America is
expected to bolster the market growth
North America is expected to hold dominant position in the global
custom recombinant protein production services market, owing to
increasing focus of regional players in research and development and
product launches. For instance, in 2014, Western Blot Service CRO, a
division of Altogen Lab, launched automated WES protein analysis and
protein expression services, providing a complete platform to conduct
protein expression studies.
Key
Players
Major players operating in the custom recombinant protein production
services market include, GenScript Biotech Corporation, Applied
Biological Materials Inc., Eurofins Pharma Discovery Services,
Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS
Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas
Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS,
LakePharma, Inc., Proteos, Inc., Aldevron, and Sino Biological Inc.
Detailed
Segmentation:
Global
Custom Recombinant Protein Production Services Market, By Expression
System:
-
Mammalian
-
Bacteria
-
Insect
-
Yeast
-
Others
Global
Custom Recombinant Protein Production Services, By End User:
-
Research Institutes
-
Biotechnology and Pharmaceutical Companies
-
Contract Research Organizations
-
Others
Browse In-Depth Analysis Research Report:
https://www.coherentmarketinsights.com/market-insight/custom-recombinant-protein-production-services-market-2737
About
Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment